# TIXiMED, Inc. — Form D

TIXiMED, Inc. of BIRMINGHAM, AL, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-05. The offering totals $550K, of which $550K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-11-05
- Form: D
- Accession: 0002043713-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $550K
- Amount sold: $550K
- Investors: 3
- Date of first sale: 2024-10-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-528704

## Issuer

- Name: TIXiMED, Inc.
- CIK: 0002043713
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1927 1ST AVENUE NORTH, BIRMINGHAM, AL, 35203
- Phone: 205-578-1005

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Thomas Michael Goodrich II | Director | Birmingham, AL |
| Aneth Michael Shalev | Director | Birmingham, AL |
| Thomas Michael Goodrich II | Executive Officer | Birmingham, AL |

## More

- [CIK 2043713 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2043713&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002043713-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.